New Delhi, 11 Oct 2022: The Indian Patent Office (IPO) has granted a patent application submitted by the National Institute of Pharmaceutical Education and Research (NIPER), Mohali, for the rights of a compound as anti-tubercular agents and an improved process for its preparation......
View Details

Related News

• IIT-BHU developing med device with potential to cure sclerosis (28-11-2024)

---

• Three widely used BP medicines Combo, five times more effective than current drugs (19-11-2024)

---

• More than half of patients with rheumatic, musculoskeletal disease use OTC supplements: Study (18-11-2024)

---

• One-third of older people and individuals admitted to the hospital experienced ADRs: Study (17-11-2024)

---

• Antithrombotic coating with sheltered positive charges prevents contact activation by controlling factor XII–biointerface binding (13-11-2024)

---

• IISc scientists develop enzyme-based solution to break antibiotic-resistant biofilms (13-11-2024)

---

• Japan performs world's first stem cell-treatment to restore vision (12-11-2024)

---

• Scientist treated her own cancer with viruses she grew in the lab (12-11-2024)

---

• Innovative use of silk in medical devices (10-11-2024)

---

• Three-fold throughput nitrosamine analysis in drug products using SIFT-MS (07-11-2024)

---